 |
 |
Vaccine Discovery Research |
New
awards
May 2003 |
The TDR Vaccine Discovery Research Committee met in Geneva, Switzerland,
May 2003, to deliberate and recommend projects for funding by TDR.
The projects listed below were selected from among a large number of
applications received from investigators worldwide.
New
grants in vaccine discovery research
Project
ID |
Principal
Investigator |
Institution |
|
Project
Title |
Funding
in US$ |
| A30118 |
Professor
Virander Singh Chauhan |
International
Centre for Genetic Engineering and Biotechnology, New Delhi, India |
|
Study
of immunogenicity & proteoctive efficacyof rodent homolgs of
P. falciparum Merozoite surface protein-9 |
36,200 |
| A30134 |
Dr
Ikram Guizani |
Institut
Pasteur de Tunis, Tunis, Tunisia |
|
Comparative
structure – function analysis of LelF, a unique Leishmania
protein bearing properties of a Th 1 type adjuvant |
35,000 |
| A30125 |
Dr
Lim Miao |
Fourth
Military Medical University, Xian China |
|
Protective
immune response induced by the combination of P. falciparum
MSP1 and AMA+ based protein, DNA & rMVA vaccine |
23,000 |
| A30158
|
Dr
Abhy Satoskar
|
Ohio
State University, Colombus, USA |
|
Development
of amastigote-specific gene chimeric vaccine against visceral leishmaniasis |
15,000
|
| A30137 |
Professor
Allen Wilson |
University
of Yourk, Department of Biology York, United Kingdom |
|
Protective
antigens in animal models of schistosome immunity |
40,000 |
| A30112 |
Dr
Michelle Wykes |
Queensland
Istitute of Medical Research, Brisbane, Queensland, Australia |
|
Regulation
of B and T cell memory to MSP1-19
|
38,208 |
| A30133 |
Dr
Seddikeh Zakeri |
Pasteur
Institute of Iran Tehran, I.R.Iran |
|
The
analysis of genetic variation in the malaria vaccine candidate
PvMSP-1 gene and evaluation of its immune response |
15,000 |
Renewed grants
in vaccine discovery research
Project
ID |
Principal
Investigator |
Institution |
|
Project
Title |
Funding
in US$ |
| A10153 |
Dr
Paul Andrew Bates |
Liverpool
School of Tropical Medicine, UK |
|
Testing
of vaccines against visceral leishmaniasis |
45,000 |
| 980455 |
Professor
Ross Leon Coppel |
Monash
University, Clayton, Australia |
|
Malaria
protein and gene database |
18,200 |
| A10161 |
Professor
Michael Francis Good |
Queensland Institute of Medical
Research, Brisbane, Australia |
|
Targets for malaria cell mediated immmunity from MSP1 and other proteins |
45,000 |
| A00265 |
Dr
Weiqing Pan |
Second
Military Medical University, Shanghai, China |
|
Pre-clinical investigation of chimeric protein consisting Plasmodium falciparum AMA-1 and 19kDa C-terminus of MSP1 |
37,700 |
| A10115 |
Dr Seyedi
Yazdy Sima Rafati |
Pasteur
Institute of Iran, Tehran, Iran |
|
Evaluation
of immune responses against L. infantum Cysteine proteinases in
Kala-azar individuals and DNA vaccinated dogs |
35,000 |
TDR expresses sincere gratitude to
members of the Vaccine Discovery Research Committee and external
reviewers for their
critical assessment and contributions to the selection process.
TDR would also like to thank those
investigators who were not funded. A large number of projects were
reviewed but only a few selected due to the highly competitive selection
process. TDR wishes to encourage these investigators to continue their
promising research and to re-compete next year (see
deadline for submission of
new applications). TDR
contact: Dr R. Ridley
|
